Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 84

1.

Menopausal symptoms and fertility concerns in premenopausal breast cancer survivors: a comparison to age- and gravidity-matched controls.

Ruddy KJ, Gelber S, Ginsburg ES, Schapira L, Abusief ME, Meyer ME, Partridge AH.

Menopause. 2011 Jan;18(1):105-8.

PMID:
21243735
[PubMed - indexed for MEDLINE]
2.

Cognitive effects of Tamoxifen in pre-menopausal women with breast cancer compared to healthy controls.

Palmer JL, Trotter T, Joy AA, Carlson LE.

J Cancer Surviv. 2008 Dec;2(4):275-82. doi: 10.1007/s11764-008-0070-1. Epub 2008 Oct 16.

PMID:
18923905
[PubMed - indexed for MEDLINE]
3.

Controversies in the management of patients with breast cancer: adjuvant endocrine therapy in premenopausal women.

Parton M, Smith IE.

J Clin Oncol. 2008 Feb 10;26(5):745-52. doi: 10.1200/JCO.2007.14.3016. Review. No abstract available.

PMID:
18258982
[PubMed - indexed for MEDLINE]
Free Article
4.

Ovarian overstimulation and cystic formation in premenopausal tamoxifen exposure: comparison between tamoxifen-treated and nontreated breast cancer patients.

Cohen I, Figer A, Tepper R, Shapira J, Altaras MM, Yigael D, Beyth Y.

Gynecol Oncol. 1999 Feb;72(2):202-7.

PMID:
10021302
[PubMed - indexed for MEDLINE]
5.

Adjuvant endocrine therapy for premenopausal women with early breast cancer.

Dellapasqua S, Colleoni M, Gelber RD, Goldhirsch A.

J Clin Oncol. 2005 Mar 10;23(8):1736-50. Review. No abstract available.

PMID:
15755982
[PubMed - indexed for MEDLINE]
Free Article
6.

Ovarian suppression for breast cancer: an effective treatment in search of a home.

Krop IE, Winer EP.

J Clin Oncol. 2005 Sep 1;23(25):5869-72. Epub 2005 Aug 8. No abstract available.

PMID:
16087947
[PubMed - indexed for MEDLINE]
Free Article
7.

Selection of optimal adjuvant endocrine therapy for early-stage breast cancer.

Al-Hajj A, O'Regan R.

Curr Treat Options Oncol. 2006 Mar;7(2):153-65. Review.

PMID:
16455026
[PubMed - indexed for MEDLINE]
8.

Randomized trial of adjuvant tamoxifen and/or goserelin in premenopausal breast cancer--self-rated physiological effects and symptoms.

Nystedt M, Berglund G, Bolund C, Brandberg Y, Fornander T, Rutqvist LE.

Acta Oncol. 2000;39(8):959-68.

PMID:
11207003
[PubMed - indexed for MEDLINE]
9.

Ovarian reserve in women who remain premenopausal after chemotherapy for early stage breast cancer.

Partridge AH, Ruddy KJ, Gelber S, Schapira L, Abusief M, Meyer M, Ginsburg E.

Fertil Steril. 2010 Jul;94(2):638-44. doi: 10.1016/j.fertnstert.2009.03.045. Epub 2009 May 5.

PMID:
19409543
[PubMed - indexed for MEDLINE]
10.

Comparison of endometrial changes among symptomatic tamoxifen-treated and nontreated premenopausal and postmenopausal breast cancer patients.

Cheng WF, Lin HH, Torng PL, Huang SC.

Gynecol Oncol. 1997 Aug;66(2):233-7.

PMID:
9264568
[PubMed - indexed for MEDLINE]
11.

[Hormone therapy in breast cancer: the end of tamoxifen?].

Delozier T.

Bull Cancer. 2005 Feb;92(2):142-50. Review. French.

PMID:
15749643
[PubMed - indexed for MEDLINE]
12.

Adjuvant endocrine therapy in premenopausal women with breast cancer.

González Martín A, de la Cruz S, Márquez R.

Breast Cancer Res Treat. 2010 Sep;123 Suppl 1:43-7. doi: 10.1007/s10549-010-1045-2. Epub 2010 Aug 14. No abstract available.

PMID:
20711666
[PubMed - indexed for MEDLINE]
13.

Side effects of adjuvant endocrine treatment in premenopausal breast cancer patients: a prospective randomized study.

Nystedt M, Berglund G, Bolund C, Fornander T, Rutqvist LE.

J Clin Oncol. 2003 May 1;21(9):1836-44.

PMID:
12721261
[PubMed - indexed for MEDLINE]
Free Article
14.

Tamoxifen treatment after adjuvant chemotherapy has opposite effects on bone mineral density in premenopausal patients depending on menstrual status.

Vehmanen L, Elomaa I, Blomqvist C, Saarto T.

J Clin Oncol. 2006 Feb 1;24(4):675-80.

PMID:
16446340
[PubMed - indexed for MEDLINE]
Free Article
15.

Plasma lipids and lipoprotein alterations in tamoxifen-treated breast cancer women in relation to the menopausal status.

Ilanchezhian S, Thangaraju M, Sachdanandam P.

Cancer Biochem Biophys. 1995 Nov;15(2):83-90.

PMID:
8590439
[PubMed - indexed for MEDLINE]
16.

Bone mineral density among premenopausal women with early breast cancer in a randomized trial of adjuvant endocrine therapy.

Sverrisdóttir A, Fornander T, Jacobsson H, von Schoultz E, Rutqvist LE.

J Clin Oncol. 2004 Sep 15;22(18):3694-9.

PMID:
15365065
[PubMed - indexed for MEDLINE]
Free Article
17.

Adjuvant endocrine therapy for premenopausal women with early breast cancer.

Bao T, Davidson NE.

Breast Cancer Res. 2007;9(6):115. doi: 10.1186/bcr1830.

PMID:
18190722
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Menopausal-type symptoms in young breast cancer survivors.

Leining MG, Gelber S, Rosenberg R, Przypyszny M, Winer EP, Partridge AH.

Ann Oncol. 2006 Dec;17(12):1777-82. Epub 2006 Sep 13.

PMID:
16971671
[PubMed - indexed for MEDLINE]
Free Article
19.

Tamoxifen reduces the risk of contralateral breast cancer in premenopausal women: Results from a controlled randomised trial.

Alkner S, Bendahl PO, Fernö M, Nordenskjöld B, Rydén L; South Swedish and South-East Swedish Breast Cancer Groups.

Eur J Cancer. 2009 Sep;45(14):2496-502. doi: 10.1016/j.ejca.2009.05.022. Epub 2009 Jun 15.

PMID:
19535242
[PubMed - indexed for MEDLINE]
20.

Effect of systemic adjuvant treatment on risk for contralateral breast cancer in the Women's Environment, Cancer and Radiation Epidemiology Study.

Bertelsen L, Bernstein L, Olsen JH, Mellemkjaer L, Haile RW, Lynch CF, Malone KE, Anton-Culver H, Christensen J, Langholz B, Thomas DC, Begg CB, Capanu M, Ejlertsen B, Stovall M, Boice JD Jr, Shore RE; Women's Environment, Cancer and Radiation Epidemiology Study Collaborative Group, Bernstein JL.

J Natl Cancer Inst. 2008 Jan 2;100(1):32-40. Epub 2007 Dec 25.

PMID:
18159070
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk